Send to KindleRon Leuty recently wrote a blog titled “Who is biotech’s Steve Jobs?”
This is a really good question! Why is there not a Steve Jobs, Mark Zuckerberg, or Bill Gates?
Ron suggests that the industry culture is timid and conservative, starting with how the scientific culture can punish those with “out of the box” thinking and adding how the NIH “has trouble funding things that are high-risk, high-reward” by rewarding incremental advancements with grants.
I recently had the pleasure of listening to Paul Hastings of OncoMed and Jay Keasling of UC-Berkeley and the Joint BioEnergy Institute. I’d nominate either one. But they do need to be ubiquitous as Ron suggests.
Who would you nominate?
The post Who is biotech’s Steve Jobs? appeared first on Hampton & Associates, Scientific & Executive Search Services.